Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$186,132,326
+$92,299,389 QoQ
Shares Held
732,891
+90.9% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#212
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $3,310,037,044 across 15 Drug Manufacturers - General names. JNJ ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,461,449 | $1,122,679,024 | |
| 2 | PFE |
Pfizer Inc
|
20,825,845 | $501,486,346 | |
| 3 | AMGN |
Amgen Inc
|
1,372,553 | $497,028,892 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,852,266 | $366,516,180 | |
| 5 | LLY |
ELI LILLY & Co
|
255,206 | $306,101,756 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
732,891 | $186,132,326 | |
| 7 | SNY |
Sanofi
|
3,849,802 | $164,232,552 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
868,399 | $109,713,528 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,132,326 | 732,891 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $93,832,937 | 383,869 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $501,276,151 | 2,422,209 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $638,977,899 | 3,446,111 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $422,543,007 | 2,766,239 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $482,808,830 | 2,911,293 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $449,532,467 | 3,108,370 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $339,813,402 | 2,096,837 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $164,652,015 | 1,126,519 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $127,393,253 | 805,318 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $129,664,730 | 827,260 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $97,169,619 | 623,882 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $123,018,269 | 743,223 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $114,394,495 | 738,029 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $101,499,555 | 574,580 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $75,824,686 | 464,157 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $91,112,509 | 513,281 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $116,459,072 | 657,107 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $107,434,011 | 628,012 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $95,746,565 | 592,858 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $103,712,065 | 629,550 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $95,423,580 | 580,612 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $79,572,112 | 505,605 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $74,593,941 | 501,034 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $108,604,047 | 772,268 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $89,213,114 | 680,341 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||